๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Michael Ulz

Stock Analyst at Morgan Stanley

(0.68)
# 4,266
Out of 5,189 analysts
609
Total ratings
39%
Success rate
-1.7%
Average return

Stocks Rated by Michael Ulz

Celldex Therapeutics
Nov 20, 2026
Reiterated: Buy
Price Target: $61
Current: $27.42
Upside: +122.47%
ADARx Pharmaceuticals
Nov 16, 2026
Maintained: Buy
Price Target: $32
Current: $12.79
Upside: +150.20%
Aardvark Therapeutics
Nov 16, 2026
Maintained: Sell
Price Target: $3
Current: $0.9226
Upside: +225.17%
Rocket Pharmaceuticals
Nov 16, 2026
Maintained: Hold
Price Target: $5
Current: $1.95
Upside: +156.41%
Viking Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $95
Current: $24.77
Upside: +283.53%
Arrowhead Pharmaceuticals
Nov 13, 2026
Reiterated: Buy
Price Target: $120 → $106
Current: $41.37
Upside: +156.22%
Attovia Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $40
Current: $15.10
Upside: +164.90%
Ionis Pharmaceuticals
Nov 10, 2026
Rated: Buy
Price Target: $104 → $75
Current: $26.58
Upside: +182.17%
Vir Biotechnology
Nov 10, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $8.39
Upside: +233.73%
Zentalis Pharmaceuticals
Nov 10, 2026
Rated: Hold
Price Target: $5
Current: $1.36
Upside: +267.65%
Reiterated: Buy
Price Target: $13
Current: $0.9361
Upside: +1,288.74%
Rated: Buy
Price Target: $36
Current: $15.50
Upside: +132.26%
Rated: Hold
Price Target: $25
Current: $13.33
Upside: +87.55%
Reiterated: Buy
Price Target: $38
Current: $26.36
Upside: +44.16%
Rated: Buy
Price Target: $152
Current: $96.13
Upside: +58.12%
Rated: Buy
Price Target: $34
Current: $8.34
Upside: +307.67%
Reiterated: Buy
Price Target: $150 → $146
Current: $112.36
Upside: +29.94%
Rated: Buy
Price Target: $28
Current: $5.45
Upside: +413.76%
Rated: Hold
Price Target: $300 → $240
Current: $143.82
Upside: +66.88%
Rated: Buy
Price Target: $146 → $150
Current: $115.31
Upside: +30.08%
Reiterated: Hold
Price Target: $24 → $4
Current: $0.82
Upside: +387.80%
Rated: Buy
Price Target: $33
Current: $4.26
Upside: +674.65%
Rated: Buy
Price Target: $25 → $32
Current: $19.81
Upside: +61.53%
Reiterated: Hold
Price Target: $23 → $20
Current: $4.28
Upside: +367.29%
Reiterated: Buy
Price Target: $2
Current: $0.2866
Upside: +597.84%
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.000001
Upside: +35,999,900.00%
Reiterated: Buy
Price Target: $5
Current: $7.56
Upside: n/a
Reiterated: Hold
Price Target: $5
Current: $0.919
Upside: n/a
Downgraded: Hold
Price Target: $20 → $5
Current: $9.41
Upside: n/a
Reiterated: Sell
Price Target: $0.5
Current: $1.28
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.77
Upside: n/a
Reiterated: Hold
Price Target: $40
Current: $33.31
Upside: n/a
Rated: Buy
Price Target: $60 → $23
Current: $6.90
Upside: n/a
Downgraded: Hold
Price Target: $3
Current: $3.72
Upside: n/a
Reiterated: Hold
Price Target: $7 → $3
Current: $20.73
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $60.41
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.3698
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $25.56
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $22.15
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $16.48
Upside: n/a
Reiterated: Buy
Price Target: $340
Current: $925.70
Upside: n/a
Reiterated: Hold
Price Target: $69 → $60
Current: $7.45
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $12.85
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $1.41
Upside: n/a
Reiterated: Buy
Price Target: $37
Current: $8.72
Upside: n/a
Initiated Coverage: Buy
Price Target: $45
Current: $7.36
Upside: n/a
Reiterated: Buy
Price Target: $15 → $8
Current: $0.00001
Upside: n/a
Reiterated: Hold
Price Target: $3 → $40
Current: $2.28
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $3.58
Upside: n/a
Reiterated: Buy
Price Target: $28
Current: $166.43
Upside: n/a